1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY TYPE
5.1. Introduction
5.2. Solutions
5.3. Services
6. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY APPLICATION
6.1. Introduction
6.2. Electronic Health Records (EHR) Interoperability
6.3. Medical Device Interoperability
6.4. Health Information Exchange (HIE)
6.5. Telehealth Interoperability
6.6. Public Health Information Exchange
6.7. Others
7. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY END-USER
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Care Centers
7.4. Diagnostic Laboratories
7.5. Others
8. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY DEPLOYMENT MODEL
8.1. Introduction
8.2. On-premise
8.3. Cloud-based
8.4. Hybrid
9. HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. USA
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Others
9.4. Europe
9.4.1. Germany
9.4.2. France
9.4.3. United Kingdom
9.4.4. Spain
9.4.5. Others
9.5. Middle East and Africa
9.5.1. Saudi Arabia
9.5.2. UAE
9.5.3. Others
9.6. Asia Pacific
9.6.1. China
9.6.2. India
9.6.3. Japan
9.6.4. South Korea
9.6.5. Indonesia
9.6.6. Thailand
9.6.7. Others
10. COMPETITIVE ENVIRONMENT AND ANALYSIS
10.1. Major Players and Strategy Analysis
10.2. Market Share Analysis
10.3. Mergers, Acquisitions, Agreements, and Collaborations
10.4. Competitive Dashboard
11. COMPANY PROFILES
11.1. Epic Systems Corporation
11.2. Cerner Corporation
11.3. Veradigm LLC (Formerly AllScripts)
11.4. InterSystems Corporation
11.5. Orion Health Group of Companies
11.6. Infor, Inc.
11.7. NXGN Management, LLC
11.8. Koninklijke Philips N.V.
11.9. OSP Labs
11.10. Optum, Inc. (a subsidiary of UnitedHealth Group)
12. APPENDIX
12.1. Currency
12.2. Assumptions
12.3. Base and Forecast Years Timeline
12.4. Key benefits for the stakeholders
12.5. Research Methodology
12.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES